ARCHIVES

Group Chairmen Reject DCT’s Agenda For Clinical Trials Review, demand Right To Select Speakers

This article is from The Cancer Letter archive.

Vol. 04 No. 26 | June 30, 1978

Download PDF Visit The Full Archive

Related Articles

Breslow Says NCI, Centers, States Should Collaborate On Cancer Control

June 1, 1984

Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol

March 5, 1999

NCI blocked groups from phase III Iressa studies.

April 30, 2004

Childhood Cancer Foundation Names New President

September 20, 2002

Investigational Drug Radium-223 Chloride Improved Overall Survival By 44 Percent

September 30, 2011

NCI Offers Chlorozotocin

November 18, 1977